| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vaxart, Inc. (VXRT) has 11 insiders with recent SEC Form 4 filings, including 33 buys and 0 sells. VXRT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Pres | 2.61M | $1.83M | - | |
| CFO | 1.00M | $700.0K | - | |
| Other | 958.0K | $670.6K | - | |
| VP | 923.2K | $646.2K | - | |
| VP | 791.8K | $554.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 7, 2019 | Armistice Capital, LLC56 | Director, 10% Owner | Buy | 200,000 | $0.34 | $67,256.18 | +0.1% | |
| Oct 11, 2019 | Richard John P | Director | Buy | 20,000 | $0.38 | $7,680.00 | New | |
| Oct 7, 2019 | Armistice Capital, LLC56 | 10% Owner | Buy | 564,000 | $0.36 | $203,200.00 | +0.6% | |
| Oct 3, 2019 | Armistice Capital, LLC56 | 10% Owner | Buy | 436,000 | $0.35 | $150,551.93 | +0.3% | |
| Sep 30, 2019 | Latour Wouter | President And Chief Executive | Buy | 166,667 | $0.30 | $50,000.10 | New | |
| Sep 30, 2019 | Armistice Capital, LLC56 | 10% Owner | Buy | 7,333,333 | $0.29 | $2,143,078.47 | +5.7% | |
| Apr 11, 2019 | Tucker Sean | Chief Scientific Officer | Buy | 27,273 | $1.10 | $30,000.30 | +107.4% | |
| Apr 11, 2019 | Finney Michael J. | Director | Buy | 181,818 | $1.10 | $199,999.80 | +67.2% | |
| Jun 5, 2018 | Finney Michael J. | Director | Buy | 5,000 | $3.40 | $17,021.35 | +0.4% | |
| Feb 9, 2016 | Colonnese Mark P | Chief Financial Officer | Buy | 7,000 | $1.41 | $9,846.58 | +2,333% |